UCB News Profile Banner
UCB News Profile
UCB News

@ucb_news

11,241
Followers
1,809
Following
1,644
Media
3,280
Statuses

A global biopharma company focusing on creating value for people living with neurology and immunology diseases. We are inspired by patients, driven by science.

Headquarters, Brussels
Joined July 2010
Don't wanna be here? Send us removal request.
@ucb_news
UCB News
3 days
Ahead of the 15th #ImmunologySummit , we’re looking back on some memories shared by previous delegates. From plenaries showcasing the latest clinical innovations to unparalleled networking opportunities, we're proud to serve the immunology community with each edition.
Tweet media one
Tweet media two
Tweet media three
0
0
0
@ucb_news
UCB News
6 days
🌟 Together, we hope to achieve more! 🌟 We partner with @ClearPointNeuro as we share a dedication to innovation in the neurology space. You can read more here #Collaboration
0
3
20
@ucb_news
UCB News
7 days
At UCB, we’re committed to improving quality of life for those living with #RareDiseases like #MyastheniaGravis (MG). Listening to those living with MG helps us better identify and address unmet needs. Read more in Manuela’s @PharmaTimes piece:
0
0
1
@ucb_news
UCB News
8 days
At UCB, we believe that everyone living with #epilepsy should understand their risk of Sudden Unexpected Death in Epilepsy (SUDEP). Hear from Andrea Wilkinson about our commitment to understanding SUDEP. #SUDEPActionDay
Tweet media one
0
1
4
@ucb_news
UCB News
8 days
Today is #SUDEPActionDay ! Together, we can raise awareness about Sudden Unexpected Death in Epilepsy (SUDEP), empowering those living with #epilepsy to understand their risks, tackle unmet needs and take the necessary actions to live more safely. #OurRisksOurRights Learn
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
1
@ucb_news
UCB News
9 days
We’re excited to join leading research scientists this week at #AANEM2024 as we present our latest research and innovations! With focus and care, we hope to come together to create real change and improvements for people with #MG . Learn more:
0
0
1
@ucb_news
UCB News
10 days
As we gather at this year’s #AANEM2024 we look forward to discussing the latest scientific advances in #MyastheniaGravis (MG) and providing new insights on treatment management to benefit the quality of life of those living with MG. Learn more about MG here:
0
0
1
@ucb_news
UCB News
13 days
For healthcare professionals only. 👏 A successful Pre-Congress Day at FFN EU 2024! Co-chairs Prof Kassim Javaid and Mr Andrew Gray led discussions on a multidisciplinary approach to secondary fracture prevention. Continue the conversation with our podcast:
Tweet media one
0
0
2
@ucb_news
UCB News
13 days
FOR MEDIA: UCB showcases extensive data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session Read more:
Tweet media one
0
0
0
@ucb_news
UCB News
14 days
For healthcare professionals only. 🚀 Today kicks off the FFN European Congress 2024! We're looking forward to the pre-congress day session on post-fracture care, highlighting available resources through the FLS Academy & Network. 👉
Tweet media one
0
0
0
@ucb_news
UCB News
15 days
Meet the co-chairs for the 15th International #ImmunologySummit ! Professor Filip Van den Bosch, Professor Brian Kirby and Professor Bene Langdahl.
Tweet media one
0
0
0
@ucb_news
UCB News
16 days
Great news from Rwanda 🇷🇼, where one of our antiseizure medicines is now publicly available and reimbursed. 💊 A step forward in our commitment to making a difference for people with epilepsy in underserved communities. 🌍 Read more: #epilepsy
Tweet media one
0
1
2
@ucb_news
UCB News
21 days
From manufacturing challenges to evolving regulations, cell and gene therapy (CGT) development is anything but simple. Discover how we can navigate these challenges in an interview with Clinical Leader and UCB’s Head of US Research, Roger Palframan here:
Tweet media one
0
0
0
@ucb_news
UCB News
24 days
Have you been a part of the #ImmunologySummit over the last 15 years? Swipe to discover the highlights from the previous editions!
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
0
@ucb_news
UCB News
27 days
Events like #EADV2024 are important opportunities to work together and shape the future of dermatology.
0
0
0
@ucb_news
UCB News
29 days
Our participation in the Landmark study underscores UCB's commitment to elevating the care for those living with #Parkinson 's. With the help of cutting-edge technology and our partners, we aim to gather new insights into this condition. Learn more:
Tweet media one
0
0
0
@ucb_news
UCB News
30 days
FOR MEDIA: We’re pleased to announce positive topline results from our phase 3 trial in Systemic Lupus Erythematosus (SLE)
Tweet media one
0
0
2
@ucb_news
UCB News
1 month
Since 2010 we’ve welcomed 6,500+ delegates from 63 countries to the #ImmunologySummit . The Summit is an important part of our long-term commitment to driving innovation in patient care and we look forward to uniting the community for the 15th anniversary in Prague this November.
0
0
0
@ucb_news
UCB News
1 month
FOR MEDIA: The U.S. #FDA has approved a new treatment option for adults with active #PsA , adults with active #nr -axSpA with objectives signs of inflammation, and adults with active #AS . Find out more:
Tweet media one
0
0
2
@ucb_news
UCB News
1 month
Our gene therapy collaboration with @KU_Leuven is built on trust. Through open dialogue & mutual respect, we've built a foundation that empowers us to tackle complex challenges together. This fuels a shared mission of driving impact in healthcare innovation. Learn more here
0
0
1